Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA
FMS
Valuace
50
Růst
40
Zdraví
66
Cena
$ 23.80
Dnes
+0.32 (1.48%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
14.0B
Obrat
20B
Zisk
1B
Aktiva
31B
Dluh
10B
ROE
6%
ROA
2%
PE
13
PS
1
Cena 1R
21-30
⌀ Cena
25.64
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
24-02-2026
Poslední dividenda
23-05-2025

Profil

Fresenius Medical Care AG & Co. KGaA poskytuje dialyzační péči a související dialyzační péči v Německu, Severní Americe a v mezinárodním měřítku. Nabízí dialyzační léčbu a související laboratorní a diagnostické služby prostřednictvím sítě ambulantních dialyzačních klinik; materiály, školení a služby na podporu pacientů zahrnující klinické monitorování, následnou pomoc a zajištění dodávek do místa bydliště pacienta; a dialyzační služby na základě smlouvy s nemocnicemi ve Spojených státech pro hospitalizované pacienty s terminálním onemocněním ledvin (ESRD) a pro pacienty s akutním selháním ledvin. Společnost také vyvíjí, vyrábí a distribuuje dialyzační produkty, včetně polysulfonových dialyzátorů, hemodialyzačních strojů, peritoneálních dialyzačních cyklů, peritoneálních dialyzačních roztoků, hemodialyzačních koncentrátů, roztoků a granulátů, krevních linií, renálních léčiv a systémů pro úpravu vody; a nedialyzační produkty, jako jsou produkty akutního kardiopulmonárního a aferézního systému. Kromě toho vyvíjí, získává a licencuje renální léčiva, nabízí renální léky a zásoby pro pacienty v domácnostech nebo na dialyzačních klinikách a poskytuje cévní, kardiovaskulární, endovaskulární specializaci, ambulantní chirurgické centrum pro cévní péči a nefrologické a kardiologické služby pro lékaře. Společnost prodává své výrobky dialyzačním klinikám, nemocnicím a specializovaným léčebným klinikám přímo, stejně jako prostřednictvím místních prodejních sil, nezávislých distributorů, dealerů a obchodních zástupců. K 23. únoru 2022 provozovala 4 171 ambulantních dialyzačních klinik v přibližně 150 zemích. Společnost Fresenius Medical Care AG & Co. KGaA byla založena v roce 1996 a sídlí v Bad Homburgu v Německu.
Sektor
Healthcare
Odvětví
Medical - Care Facilities
Počet zaměstnanců
112035
Založení
1996-09-17
Adresa
Else-KrOener Strasse 1
CEO
Helen Giza

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliardách (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues19.6319.6319.3419.4519.4017.6217.8617.4816.5517.7817.0315.3113.0210.5810.439.879.06
Cost of Revenues14.6014.6014.5814.5314.0912.5412.3212.0811.3911.7811.5310.438.917.156.966.385.95
Gross Profit5.035.034.764.935.315.085.545.405.166.005.504.884.113.433.483.493.12
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues5.074.884.794.885.084.764.774.724.994.94
Cost of Revenues3.683.643.583.703.813.613.603.553.643.71
Gross Profit1.391.241.211.181.271.151.171.171.351.23
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.000.000.000.230.230.220.190.170.130.130.150.130.100.090.080.090.07
Selling General & Admin Expenses0.000.000.003.203.783.103.173.062.873.582.902.652.181.731.681.831.60
Depreciation & Amortization1.521.441.741.751.841.621.791.590.730.740.740.660.570.470.460.430.38
Total Operating Expenses3.203.203.363.564.013.323.363.233.003.713.052.782.281.821.841.891.67
Operating Income1.831.831.391.37-0.260.300.530.713.042.362.512.131.851.631.681.601.45
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.000.000.000.000.000.000.000.000.070.05
Selling General & Admin Expenses0.000.000.000.000.000.000.000.000.850.79
Depreciation & Amortization0.350.390.380.390.000.370.390.510.400.39
Total Operating Expenses0.800.770.790.851.010.680.740.930.910.93
Operating Income0.590.480.430.330.260.460.430.250.440.32
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income0.040.000.070.090.070.070.040.060.150.040.040.110.070.030.030.050.02
Interest Expense0.270.000.410.420.360.350.410.490.450.400.430.460.410.320.360.270.23
Other Expense-0.31-0.32-0.34-0.341.481.271.411.130.880.070.060.030.020.030.150.02-0.21
IBT1.511.511.061.031.221.571.941.842.742.012.121.771.521.341.461.371.24
Income Tax Expense0.320.320.320.300.330.350.500.400.510.450.650.570.480.430.460.460.43
Net Income0.980.980.540.500.670.971.161.201.981.281.180.940.860.800.900.830.74
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.000.000.020.010.020.020.020.020.030.03
Interest Expense0.000.070.100.100.100.100.100.100.090.11
Other Expense-0.09-0.07-0.07-0.08-0.08-0.08-0.09-0.09-0.08-0.09
IBT0.510.400.350.250.180.380.340.160.320.24
Income Tax Expense0.110.080.080.060.060.120.100.040.090.09
Net Income0.330.270.230.150.070.210.190.070.190.08
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$1.70$1.15$1.66$1.98$1.98$3.23$2.09$1.87$1.57$1.42$1.32$1.47$1.37$1.22
EPS Diluted$0.00$0.00$0.00$1.70$1.15$1.66$1.98$1.98$3.23$2.08$1.87$1.57$1.42$1.32$1.46$1.35$1.22
Shares Outstanding0.570.580.590.290.590.590.590.610.610.610.610.610.600.610.610.610.60
Diluted Shares Outstanding0.570.580.590.290.590.590.590.610.610.620.610.610.610.610.610.610.60
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.64$0.29
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.64$0.29
Shares Outstanding0.570.580.590.591.171.171.171.170.290.29
Diluted Shares Outstanding0.570.580.590.591.171.171.171.170.290.29
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents1.091.181.401.271.481.081.012.150.980.710.500.520.490.520.350.39
Short Term Investments0.000.160.140.170.140.160.130.100.000.250.250.140.000.000.000.00
Total Cash & ST Investments1.091.341.541.441.621.241.142.150.980.960.750.660.490.520.350.39
Accounts Receivable4.063.413.644.033.913.623.973.773.704.153.803.322.652.582.242.02
Inventory2.232.072.182.302.041.901.661.471.291.341.230.920.790.780.750.61
Other Current Assets1.311.101.340.350.340.460.320.260.310.230.210.260.250.361.050.85
Total Current Assets8.697.928.708.207.977.287.177.856.376.956.395.534.554.634.393.87
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents1.261.721.071.181.371.091.151.401.551.36
Short Term Investments0.000.470.000.160.000.000.000.140.000.00
Total Cash & ST Investments1.262.191.071.341.371.091.151.541.551.36
Accounts Receivable3.283.233.593.413.284.064.054.063.713.65
Inventory2.092.002.082.072.102.232.222.182.302.34
Other Current Assets1.210.721.221.101.341.311.871.331.481.00
Total Current Assets7.828.147.967.928.098.699.288.709.058.35
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment7.267.267.454.194.324.138.523.843.493.593.132.712.242.222.031.90
Goodwill14.8115.1714.6515.7914.3612.9614.0212.2112.1012.9911.9210.768.448.647.096.12
Intangible Assets1.351.371.361.521.461.381.430.680.680.810.760.710.550.547.620.52
Long-Term Investments1.371.121.080.770.790.760.700.650.650.650.590.560.480.480.530.19
Other Long-Term Assets0.130.720.684.975.164.830.750.670.410.430.430.550.400.270.430.18
Total Long-Term Assets25.2125.6425.2327.5526.4024.4125.7718.4017.6518.6616.9715.4012.1912.2510.688.98
Total Assets33.9033.5733.9335.7534.3731.6932.9426.2424.0325.6123.3520.9316.7416.8815.0712.85
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment6.406.506.987.266.987.267.317.457.897.93
Goodwill13.5913.6214.6415.1714.2314.8114.6814.6515.4115.42
Intangible Assets1.251.251.331.371.311.351.361.361.411.40
Long-Term Investments0.751.340.671.120.690.650.621.250.710.70
Other Long-Term Assets1.080.211.160.721.221.131.100.220.870.85
Total Long-Term Assets23.0623.1624.7825.6424.4225.2125.0525.2326.5826.61
Total Assets30.8931.2932.7433.5732.5133.9034.3433.9335.6334.96
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable0.780.980.840.930.860.830.840.800.740.840.710.590.480.560.420.32
Short-Term Debt1.421.221.562.042.591.703.262.501.651.300.720.370.490.351.320.71
Other Current Liabilities3.593.093.353.393.303.032.912.902.630.840.860.760.690.621.970.47
Current Liabilities5.945.666.116.477.266.167.016.275.304.793.832.862.572.403.292.85
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable0.830.750.900.980.770.780.840.840.830.81
Short-Term Debt1.141.601.311.221.651.421.521.591.912.26
Other Current Liabilities3.803.143.083.093.293.593.623.353.663.37
Current Liabilities5.765.665.455.665.895.946.206.116.626.62
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt6.859.7610.4911.1810.7410.6810.525.055.796.857.187.475.615.934.243.24
Capital Leases3.484.144.154.684.750.614.710.000.000.000.000.000.000.000.000.00
Def. Tax Liability0.690.710.000.940.870.790.740.630.470.640.690.660.540.500.450.38
Total Liabilities18.7117.8019.1020.3120.3919.3619.7113.3413.2014.7213.7512.689.879.928.857.20
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt9.349.429.519.769.5610.3310.5110.4911.0710.81
Capital Leases3.613.683.994.143.924.104.114.154.454.46
Def. Tax Liability0.000.610.670.710.650.000.710.750.850.86
Total Liabilities16.9816.9617.2317.8017.7218.7119.2019.1020.2020.03
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.290.290.290.290.290.290.300.310.310.360.350.320.280.28-0.190.00
Retained Earnings10.8711.2710.9210.7110.8310.259.458.837.148.407.205.844.624.213.592.90
Comprehensive Income-0.62-0.33-0.98-0.39-1.31-2.21-1.04-1.20-1.49-1.25-1.22-0.89-0.40-0.37-0.37-0.15
Total Common Equity13.9314.5813.6215.4513.9812.3313.2312.9010.8310.899.608.256.696.765.905.55
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.290.290.290.290.290.290.290.290.290.29
Retained Earnings11.8411.2911.4711.2711.0910.8711.0310.9210.7610.64
Comprehensive Income-1.67-1.66-0.74-0.33-1.14-0.62-0.80-0.98-0.42-0.78
Total Common Equity12.9513.2714.3714.5813.6213.9313.9113.6214.0113.53
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt11.7511.0012.0513.2113.3212.3813.787.557.458.157.917.846.106.275.563.95
Book Value15.1915.7714.8315.4513.9812.3313.2312.9010.8310.899.608.256.876.966.225.66
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.961.061.131.191.171.261.221.211.431.40
Book Value12.9513.2714.3714.5813.6213.9313.9113.6214.0113.53
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income0.640.940.740.730.901.221.441.442.231.551.471.201.040.911.000.910.80
Depreciation & Amortization1.781.411.741.751.841.621.791.590.730.740.740.660.570.470.460.430.38
Stock-Based Compensation0.030.000.000.030.00-1.69-1.900.000.010.050.030.010.010.010.020.020.02
Change Working Capital0.140.130.440.56-0.57-0.351.01-0.47-0.89-0.10-0.17-0.06-0.080.100.13-0.22-0.18
Change In Accounts Receivable-0.69-0.07-0.07-0.15-0.05-0.160.07-0.06-0.17-0.09-0.31-0.30-0.23-0.04-0.05-0.20-0.23
Change In Accounts Payable0.47-0.010.160.11-0.36-0.361.37-0.160.370.520.170.530.190.150.180.000.00
Change In Inventories0.04-0.240.11-0.01-0.20-0.05-0.36-0.12-0.16-0.06-0.06-0.28-0.07-0.04-0.04-0.120.01
Other Non-cash Items0.380.12-0.47-0.330.041.621.79-0.07-0.100.16-0.020.03-0.10-0.03-0.120.000.01
Cash from Operations2.050.000.002.632.172.494.232.572.062.192.031.791.531.471.541.121.03
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income0.330.270.270.190.070.210.190.120.190.15
Depreciation & Amortization0.370.380.380.390.390.370.380.510.430.45
Stock-Based Compensation0.000.000.000.000.040.000.000.000.030.00
Change Working Capital0.15-0.280.28-0.390.000.50-0.09-0.420.120.33
Change In Accounts Receivable0.09-0.060.18-0.290.030.46-0.01-0.55-0.08-0.05
Change In Accounts Payable-0.100.00-0.08-0.110.000.000.000.13-0.030.16
Change In Inventories-0.06-0.10-0.02-0.070.100.07-0.02-0.040.040.06
Other Non-cash Items0.130.36-0.13-0.010.33-0.10-0.04-0.04-0.190.09
Cash from Operations0.000.000.000.000.000.000.000.000.720.76
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-0.69-0.88-0.70-0.68-1.41-1.68-2.09-2.24-2.06-1.79-1.94-1.73-1.52-0.54-0.51-1.84-0.39
Acquisitions0.680.220.610.140.00-0.38-0.24-2.170.76-0.15-0.35-0.06-1.46-0.35-1.220.01-0.46
Investments-0.04-0.09-0.08-0.10-0.11-0.13-0.10-2.17-0.93-0.15-0.35-0.06-1.46-0.36-1.420.000.00
Sales of Investment0.040.080.080.090.060.140.041.110.00-0.42-0.20-0.23-0.010.000.000.000.00
Other Investing Activities0.010.000.000.020.720.851.052.181.981.511.531.162.230.371.430.020.01
Cash from Investing0.010.000.00-0.54-0.73-1.20-1.33-3.29-0.25-0.99-1.31-0.92-2.21-0.87-1.72-1.81-0.85
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.41-0.19-0.15-0.15-0.24-0.17-0.16-0.13-0.25-0.14
Acquisitions0.050.00-0.010.010.02-0.01-0.010.040.13-0.01
Investments-0.060.000.00-0.010.000.000.000.000.00-0.04
Sales of Investment0.030.000.010.030.000.000.000.020.010.02
Other Investing Activities0.000.000.000.000.000.000.000.000.010.00
Cash from Investing0.000.000.000.000.000.000.000.00-0.10-0.15
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-1.370.000.00-1.26-2.82-3.41-4.18-4.16-1.32-1.46-1.20-0.62-1.79-0.75-2.89-1.03-1.00
Debt Issued0.0611.00-1.050.102.714.352.7810.401.420.751.450.693.530.573.602.644.95
Issuance of Common Stock0.000.000.000.000.000.002.934.501.531.200.000.000.000.030.002.420.00
Repurchase of Common Stock0.00-0.560.000.000.000.00-0.37-0.60-0.04-0.060.000.000.00-0.370.00-0.500.00
Dividends Paid-0.350.000.00-0.33-0.40-0.39-0.35-0.35-0.32-0.29-0.26-0.24-0.26-0.21-0.21-0.22-0.17
Other Financing Activities-0.420.000.00-0.271.602.78-0.690.15-0.53-0.190.91-0.062.710.723.45-0.061.16
Cash from Financing-2.290.000.00-1.86-1.62-1.02-2.66-0.47-0.68-0.80-0.56-0.920.66-0.590.350.61-0.01
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.000.000.000.000.000.000.000.00-0.68-0.43
Debt Issued10.47-0.550.18-0.16-0.22-0.55-0.280.01-0.240.34
Issuance of Common Stock0.000.000.000.000.000.000.000.000.000.00
Repurchase of Common Stock-0.42-0.150.000.000.000.000.000.000.000.00
Dividends Paid0.000.000.000.000.000.000.000.000.000.00
Other Financing Activities0.000.000.000.000.000.000.000.00-0.070.02
Cash from Financing0.000.000.000.000.000.000.000.00-0.75-0.41
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-0.210.56-0.240.15-0.210.400.07-1.141.170.270.19-0.08-0.040.000.17-0.050.17
Closing Cash Balance1.091.601.191.431.271.481.081.012.150.980.710.500.520.490.520.350.39
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash0.34-0.460.64-0.11-0.200.28-0.08-0.24-0.130.21
Closing Cash Balance1.601.261.721.081.191.391.111.191.431.57
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow1.361.701.691.940.760.812.150.330.000.410.090.070.010.931.03-0.720.63
Real Free Cash Flow1.331.701.691.910.762.504.040.33-0.010.360.060.050.000.921.01-0.750.61
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow0.560.550.620.020.590.820.28-0.010.470.62
Real Free Cash Flow0.560.550.620.020.550.820.28-0.010.440.62
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E12.623.5259.1
P/S0.61.634.5
P/B0.92.2163.3
P/FCF7.126.9775.5
Market cap$14.0$14.5
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets33.9 %35.9 %0 %
Debt to Income1070.5 %1075.9 %0 %
Debt to Free cash flow598.1 %12.7 %0 %
Interest expense percentage14.6 %21.3 %60.6 %
Current ratio1.4 1.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE7.6 %10 %0 %
ROA3.2 %4 %0 %
CapEx to Revenue3.7 %6 %0 %
RaD to Revenue0 %0.9 %0 %
ROEM176,015.5 123270.6

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin25 %31 %59.4 %
Operating margin7.6 %12.9 %30.6 %
Net margin3.7 %6.7 %17.4 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0.4 %0 %
Dividend payout percentage0 %6.6 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding584.7 mil 582.3 mil
Employee count111.5 tis 94.8 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader